Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Global Value Dossier

- PMLiVE

Health Awareness: The Power and Pitfalls of Social Media

Since the creation of the first social media site in 1997 [1], the use of various social media platforms has increased exponentially. As of October 2023, there were 4.95 billion...

Mednet

Recreating the Onsite Experience with the Right Tools – Building Company Culture Virtually

Distance shouldn't hinder collaboration! This video explores how the right technology can bridge the physical gap and recreate the vibrant atmosphere of an in-office environment for your remote team in...

Impetus Digital

- PMLiVE

WHO urges US to ‘reconsider’ withdrawal from global health organisation

President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises

- PMLiVE

Takeda and EU Innovative Health Initiative launch Crohn’s disease prevention study

Approximately three million people in Europe are affected by inflammatory bowel disease

- PMLiVE

LEO pharma gains EU rights to Junshi Biosciences’ PD-1 inhibitor toripalimab

The drug was approved by the EC last year to treat nasopharyngeal and oesophageal cancer

- PMLiVE

Unlocking innovation: how generative AI and data are reshaping healthcare marketing

By Will Reese

- PMLiVE

Impactful Advances in Aesthetic Medicine

Medscape is pleased to announce new advancements within its Clinical Advances in Aesthetic Medicine. Launched in 2022, this initiative has effectively educated MD practitioners, showcasing measurable outcomes with submissions to...

Medscape Education

- PMLiVE

Sanofi’s Sarclisa granted EC approval to treat newly diagnosed multiple myeloma

Approximately 46,000 cases of the disease are expected to be diagnosed in Europe in 2025

- PMLiVE

AstraZeneca receives NICE recommendations for lung cancer drugs Tagrisso and Imfinzi

More than 49,000 people are diagnosed with lung cancer in the UK each year

- PMLiVE

Chiesi report highlights incorrect inhaler use among UK asthma patients

The long-term lung condition affects around 7.2 million people in the UK

- PMLiVE

The power of purpose

Iona Everson from PMGroup speaks to Amar Urhekar, CEO of Avalere Health, about his professional journey within healthcare marketing and his commitment to building unconventional solutions that reach patients where...

- PMLiVE

A Pulse on Innovation at the Heart of Cardiology 2025

MedscapeLIVE! is proud to present its annual Heart of Cardiology meeting, returning for its fifth year in Miami, Florida from January 24-26, 2025. Over 3 packed days at the Fontainebleau...

Medscape Education

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links